{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:49:48Z","timestamp":1757627388421,"version":"3.44.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["202201020321"],"award-info":[{"award-number":["202201020321"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by mesenchymal tumors that secrete fibroblast growth factor 23 (FGF23). Phosphaturic mesenchymal tumor (PMT) is a novel histopathologic entity that has been identified as a separate cause of TIO. Clinically, PMT is typically diagnosed late due to its rarity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>The paper reports on a patient with a sustained left-sided sub-trochanteric femur fracture in 2018 who subsequently underwent fracture reduction and internal fixation placement. Six years postoperatively, the patient developed a recurrent femoral stem fracture accompanied by internal fixation device failure on the left side of the femur with no apparent causative factors. Based on the patient\u2019s history of multiple fractures, a series of tests were performed and he was diagnosed with a rare disease recognized as TIO. A PET-CT scan conducted prior to surgery revealed that the lesion was located in the right suprapatellar bursa, so the mass was palpated on the body surface and surgically excised.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>It is the first reported case of TIO in a patient with internal fixation device failure. Following a thorough review of the patient\u2019s medical history, examination findings, and associated literature, the study concluded that the patient\u2019s long-term osteomalacia and hypophosphatemia would significantly compromise the stability of the internal fixation. Specifically, we determined that the primary tumor lesion in this case was the primary cause of internal fixation failure. Therefore, patients found to have difficult-to-correct hypophosphatemia with multiple fractures in clinical practice should be further investigated for the primary etiology, such as TIO as mentioned in this case, before fracture surgery is performed. Enhancing 68 Ga-DOTA-TATE Positron Emission Tomography\/ Computed Tomography (PET\/CT) is also recommended to provide a more precise diagnosis of the tumor. For definite tumor lesions, total excisional surgery is considered to be a viable treatment for TIO.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12891-025-09066-0","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:21:36Z","timestamp":1756743696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Failure of femoral internal fixation device secondary to phosphaturic mesenchymal tumor: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Ningjing","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningzhi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"3","key":"9066_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/joim.13593","volume":"293","author":"SM Jan de Beur","year":"2023","unstructured":"Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton\u2013Bligh R, Collins M, Florenzano P, Houillier P, et al. Global guidance for the recognition, diagnosis, and management of tumor\u2013induced osteomalacia. J Intern Med. 2023;293(3):309\u201328.","journal-title":"J Intern Med"},{"issue":"4","key":"9066_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.semdp.2019.07.002","volume":"36","author":"AL Folpe","year":"2019","unstructured":"Folpe AL. Phosphaturic mesenchymal tumors: a review and update. Semin Diagn Pathol. 2019;36(4):260\u20138.","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"9066_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3174\/ajnr.A7513","volume":"43","author":"JC Benson","year":"2022","unstructured":"Benson JC, Trejo\u2013Lopez JA, Nassiri AM, Eschbacher K, Link MJ, Driscoll CL, Tiegs RD, Sfeir J, DeLone DR. Phosphaturic mesenchymal tumor. AJNR Am J Neuroradiol. 2022;43(6):817\u201322.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"9066_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg\u2013Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, et al. Most osteomalacia\u2013associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1):1\u201330.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"9066_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1210\/endrev\/bnac026","volume":"44","author":"S Minisola","year":"2023","unstructured":"Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV. Tumor\u2013induced osteomalacia: a comprehensive review. Endocr Rev. 2023;44(2):323\u201353.","journal-title":"Endocr Rev"},{"issue":"7","key":"9066_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","volume":"64","author":"J Feng","year":"2017","unstructured":"Feng J, Jiang Y, Wang O, Li M, Xing XP, Huo L, Li F, Yu W, Zhong DR, Jin J, et al. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J. 2017;64(7):675\u201383.","journal-title":"Endocr J"},{"issue":"1","key":"9066_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00223-020-00686-3","volume":"108","author":"M Peacock","year":"2021","unstructured":"Peacock M. Phosphate metabolism in health and disease. Calcif Tissue Int. 2021;108(1):3\u201315.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"9066_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.beem.2018.06.004","volume":"32","author":"M Christov","year":"2018","unstructured":"Christov M, J\u00fcppner H. Phosphate homeostasis disorders. Best Pract Res Clin Endocrinol Metab. 2018;32(5):685\u2013706.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"9066_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/eje.0.1320251","volume":"132","author":"EF Eriksen","year":"1995","unstructured":"Eriksen EF, Brixen K, Charles P. New markers of bone metabolism: clinical use in metabolic bone disease. Eur J Endocrinol. 1995;132(3):251\u201363.","journal-title":"Eur J Endocrinol"},{"key":"9066_CR10","doi-asserted-by":"crossref","unstructured":"Cianferotti L. Osteomalacia is not a single disease. Int J Mol Sci. 2022;23(23):14896.","DOI":"10.3390\/ijms232314896"},{"issue":"12","key":"9066_CR11","first-page":"1937","volume":"48","author":"YB Yang","year":"2023","unstructured":"Yang YB, Jin PJ, Zhang ST, Chen K, He HH, Mo ZH, Yuan JJ. A case of hyperparathyroidism secondary to tumor\u2013induced osteomalacia. Zhong Nan Da Xue Xue Bao Yi Xue ban. 2023;48(12):1937\u201344.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue ban =. J Cent South Univ Med Sci"},{"issue":"4","key":"9066_CR12","first-page":"556","volume":"51","author":"MF Fu","year":"2022","unstructured":"Fu MF, Hui S. Research progress on tumor\u2013induced osteomalacia. Acta Med Univ Sci Tech Huazhong. 2022;51(4):556\u201361.","journal-title":"Acta Med Univ Sci Tech Huazhong"},{"issue":"6","key":"9066_CR13","first-page":"566","volume":"29","author":"W Li","year":"2018","unstructured":"Li W, Wang XD, Zuo QY, Wang H, Huang YH, Song H, Deng W. Treatment and clinical features of tumor\u2013induced osteomalacia: a retrospective review offifteen patients. Med J Chin People\u2019s Armed Police Forces. 2018;29(6):566\u201370.","journal-title":"Med J Chin People's Armed Police Forces"},{"issue":"6","key":"9066_CR14","first-page":"1162","volume":"39","author":"DL Wu","year":"2020","unstructured":"Wu DL, Leng X, Qiu SJ. Imaging features of osseous phosphaturic mesenchymal tumor and literature review. J Clin Radiol. 2020;39(6):1162\u20135.","journal-title":"J Clin Radiol"},{"key":"9066_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.680598","volume":"8","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Chen WJ, Wang YY, Jin JY, Zhao YR, Zhu J, Huang F. Comparative analysis of clinical and imaging features of osteomalacia and spondyloarthritis. Front Med. 2021;8: 680598.","journal-title":"Front Med"},{"issue":"9","key":"9066_CR16","first-page":"985","volume":"44","author":"Y Zhang","year":"2024","unstructured":"Hospital Pharmacy Committee of Chinese Pharmaceutical Association, Compilation Group of Expert Consensus on Rational Use of Anti-Osteoporsis Agents (2023). Chin J Hosp Pharm. 2024;44(9):985\u20131006.","journal-title":"Chinese Journal of Hospital Pharmacy"},{"issue":"1","key":"9066_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor\u2013induced osteomalacia. Calcif Tissue Int. 2021;108(1):128\u201342.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"9066_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MNM.0000000000001163","volume":"41","author":"YY Jiang","year":"2020","unstructured":"Jiang YY, Hou GZ, Cheng WY. Performance of 68Ga\u2013DOTA\u2013SST PET\/CT, Octreoscan SPECT\/CT and 18F\u2013FDG PET\/CT in the detection of culprit tumors causing osteomalacia: a meta\u2013analysis. Nucl Med Commun. 2020;41(4):370\u20136.","journal-title":"Nucl Med Commun"},{"issue":"5","key":"9066_CR19","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00256-023-04462-w","volume":"53","author":"J Gu","year":"2024","unstructured":"Gu J, Ge C, Joshi G, Most M, Tai R. Phosphaturic mesenchymal tumor: two cases highlighting differences in clinical and radiologic presentation. Skeletal Radiol. 2024;53(5):995\u20131002.","journal-title":"Skeletal Radiol"},{"key":"9066_CR20","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, et al. Tumour\u2013induced osteomalacia. Nat Rev Dis Primers. 2017;3:17044.","journal-title":"Nat Rev Dis Primers"},{"key":"9066_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, et al. Tumor localization and biochemical response to cure in tumor\u2013induced osteomalacia. J Bone Miner Res. 2013;28:1386\u201398.","journal-title":"J Bone Miner Res"},{"key":"9066_CR22","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, et al. Sensitivity of fibroblast growth factor 23 measurements in tumor\u2013induced osteomalacia. J Clin Endocrinol Metab. 2006;91:2055\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"9066_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.afos.2018.12.001","volume":"4","author":"Z Yin","year":"2018","unstructured":"Yin Z, Du J, Yu F, Xia W. Tumor\u2013induced osteomalacia. Osteoporos Sarcopenia. 2018;4:119\u201327.","journal-title":"Osteoporos Sarcopenia"},{"key":"9066_CR24","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/jbmr.4317","volume":"36","author":"SM Jan de Beur","year":"2021","unstructured":"Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, et al. Reply to: burosumab for tumor\u2013induced osteomalacia: not enough of a good thing. J Bone Min Res. 2021;36:2455\u20136.","journal-title":"J Bone Min Res"},{"key":"9066_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101826","volume":"38","author":"A Goyal","year":"2024","unstructured":"Goyal A, Tandon N. Burosumab: current status and future prospects. Best Pract Res Clin Endocrinol Metab. 2024;38: 101826.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9066_CR26","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00198-022-06432-9","volume":"33","author":"S Minisola","year":"2022","unstructured":"Minisola S, Barlassina A, Vincent S\u2013A, Wood S, Williams A. A literature review to understand the burden of disease in people living with tumour\u2013induced osteomalacia. Osteoporos Int. 2022;33:1845\u201357.","journal-title":"Osteoporos Int"},{"issue":"7","key":"9066_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.injury.2016.04.018","volume":"47","author":"CM Peeters","year":"2016","unstructured":"Peeters CM, Visser E, Van de Ree CL, Gosens T, Den Oudsten BL, De Vries J. Quality of life after hip fracture in the elderly: a systematic literature review. Injury. 2016;47(7):1369\u201382.","journal-title":"Injury"},{"issue":"2","key":"9066_CR28","first-page":"126","volume":"33","author":"PH Shi","year":"2018","unstructured":"Shi PH, Sun H, Hu H, Wang T, Guang YS, Li XL, Wang CT. Biomechanical study of three fixation systems for complex unstable femoral intertrochanteric fractures. J Med Biomech. 2018;33(2):126\u201330.","journal-title":"J Med Biomech"},{"issue":"11","key":"9066_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.injury.2011.01.030","volume":"42","author":"GC Zha","year":"2011","unstructured":"Zha GC, Chen ZL, Qi XB, Sun JY. Treatment of pertrochanteric fractures with a proximal femur locking compression plate. Injury. 2011;42(11):1294\u20139.","journal-title":"Injury"},{"issue":"6","key":"9066_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1590\/S1413-78522012000600003","volume":"20","author":"SJ Hu","year":"2012","unstructured":"Hu SJ, Zhang SM, Yu GR. Treatment of femoral subtrochanteric fractures with proximal lateral femur locking plates. Acta Ortopedica Brasileira. 2012;20(6):329\u201333.","journal-title":"Acta Ortopedica Brasileira"},{"issue":"2","key":"9066_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5704\/MOJ.1407.011","volume":"8","author":"U Gunadham","year":"2014","unstructured":"Gunadham U, Jampa J, Suntornsup S, Leewiriyaphun B. The outcome in early cases of treatment of subtrochanteric fractures with proximal femur locking compression plate. Malays Orthop J. 2014;8(2):22\u20138.","journal-title":"Malays Orthop J"},{"issue":"3","key":"9066_CR32","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.4238\/2014.August.7.10","volume":"13","author":"JJ Liu","year":"2014","unstructured":"Liu JJ, Shan LC, Deng BY, Wang JG, Zhu W, Cai ZD. Reason and treatment of failure of proximal femoral nail antirotation internal fixation for femoral intertrochanteric fractures of senile patients. Genet Mol Res. 2014;13(3):5949\u201356.","journal-title":"Genet Mol Res"},{"key":"9066_CR33","doi-asserted-by":"crossref","unstructured":"Kashigar A, Vincent A, Gunton MJ, Backstein D, Safir O, Kuzyk PR. Predictors of failure for cephalomedullary nailing of proximal femoral fractures. Bone Joint J. 2014;96\u2013b(8):1029\u20131034.","DOI":"10.1302\/0301-620X.96B8.33644"},{"issue":"3","key":"9066_CR34","first-page":"470","volume":"89","author":"H Palm","year":"2007","unstructured":"Palm H, Jacobsen S, Sonne\u2013Holm S, Gebuhr P. Integrity of the lateral femoral wall in intertrochanteric hip fractures: an important predictor of a reoperation. J Bone Joint Surg Am. 2007;89(3):470\u20135.","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"9066_CR35","first-page":"605","volume":"6","author":"LX Yu","year":"2017","unstructured":"Yu LX, Gao SZ, Shi LH, Zhang AW, Liu HT. A meta\u2013analysis about the failure of proximal femoral locking compression plates to fix intertrechanteric or subtrochanteric fractures. Chin J Bone Joint. 2017;6(8):605\u201310.","journal-title":"Chin J Bone Joint"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09066-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-09066-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09066-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T02:16:41Z","timestamp":1757470601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-09066-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9066"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-09066-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"type":"electronic","value":"1471-2474"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report does not involve any personal information and no ethical endorsement was obtained, but patient consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients gave informed written consent to the publication of their personal or clinical data and images in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"831"}}